1 study found for:    b7-dc
Show Display Options
Rank Status Study
1 Active, not recruiting Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: B7-DC cross-linking antibody rHIgM12B7;   Other: flow cytometry;   Other: immunologic technique;   Other: laboratory biomarker analysis

Indicates status has not been verified in more than two years